JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB17127

Anti-ALK antibody [5A4]

Be the first to review this product! Submit a review

|

(25 Publications)

Anti-ALK antibody [5A4] (ab17127) is a mouse monoclonal antibody detecting ALK in IHC-P. Suitable for Human.

- Over 20 publications
- Trusted since 2005

View Alternative Names

CD246, ALK tyrosine kinase receptor, Anaplastic lymphoma kinase, ALK

1 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ALK antibody [5A4] (AB17127)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ALK antibody [5A4] (AB17127)

Immunohistochemical analysis of formalin-fixed, paraffin-embedded human anaplastic lymphoma tissue, staining ALK with ab17127.

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

5A4

Isotype

IgG1

Carrier free

No

Reacts with

Human

Applications

IHC-P

applications

Immunogen

Recombinant Fragment Protein within Human ALK aa 400-550. The exact immunogen used to generate this antibody is proprietary information.

Q9UM73

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/25 - 1/70", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol." } } }

Product details

What is this antibody validated in?
Anti-ALK antibody [5A4] (ab17127) is a mouse monoclonal antibody and is validated for use in Immunohistochemistry (IHC-P) in Human samples.

Trusted by the scientific community
Anti-ALK [5A4] (ab17127) was first used in a scientific publication in 2005 and has been cited over 20 times in peer-reviewed journals.

Properties and storage information

Form
Liquid
Purity
Tissue culture supernatant
Storage buffer
pH: 7.3 - 7.5 Preservative: 0.05% Sodium azide Constituents: Tissue culture supernatant, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Anaplastic Lymphoma Kinase commonly referred to as ALK is a receptor tyrosine kinase known for its role in cell signaling. It is sometimes called CD246. ALK has a molecular mass of approximately 180 kDa. This protein finds expression predominantly in the central and peripheral nervous system with prominence in neural tissue during development. The ALK protein belongs to the insulin receptor superfamily exhibiting kinase activity that promotes signal transduction processes associated with growth and differentiation.
Biological function summary

ALK influences cell growth survival and differentiation playing a significant role during the development of the nervous system. As part of its biological activity the ALK protein can become a component of larger signaling complexes participating as an important activator or mediator. Evidence suggests ALK's involvement in neuronal differentiation and synaptogenesis. Its activity impacts intracellular pathways consequently modulating biological processes relevant to neural tissue and oncogenesis.

Pathways

ALK acts within the MAPK and PI3K-AKT signaling pathways. These pathways enable the transduction of signals from the cell surface to the nucleus influencing cellular outcomes such as proliferation and survival. In these pathways ALK interacts with various other proteins including GRB2 and PI3K which further facilitate downstream signaling. Proper functioning of these pathways is essential to maintaining cellular homeostasis and development.

ALK has a significant relationship with certain types of cancer such as non-small cell lung carcinoma and anaplastic large cell lymphoma. Genetic alterations in ALK such as translocations or mutations can lead to the uncontrolled activation of its kinase activity resulting in oncogenic transformation. In these contexts the ALK protein often interacts with EML4 in lung cancer through a fusion forming an oncogenic driver. Targeting ALK with anti-ALK antibodies or small molecule inhibitors has emerged as a therapeutic strategy to manage these malignancies.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Neuronal receptor tyrosine kinase that is essentially and transiently expressed in specific regions of the central and peripheral nervous systems and plays an important role in the genesis and differentiation of the nervous system (PubMed : 11121404, PubMed : 11387242, PubMed : 16317043, PubMed : 17274988, PubMed : 30061385, PubMed : 34646012, PubMed : 34819673). Also acts as a key thinness protein involved in the resistance to weight gain : in hypothalamic neurons, controls energy expenditure acting as a negative regulator of white adipose tissue lipolysis and sympathetic tone to fine-tune energy homeostasis (By similarity). Following activation by ALKAL2 ligand at the cell surface, transduces an extracellular signal into an intracellular response (PubMed : 30061385, PubMed : 33411331, PubMed : 34646012, PubMed : 34819673). In contrast, ALKAL1 is not a potent physiological ligand for ALK (PubMed : 34646012). Ligand-binding to the extracellular domain induces tyrosine kinase activation, leading to activation of the mitogen-activated protein kinase (MAPK) pathway (PubMed : 34819673). Phosphorylates almost exclusively at the first tyrosine of the Y-x-x-x-Y-Y motif (PubMed : 15226403, PubMed : 16878150). Induces tyrosine phosphorylation of CBL, FRS2, IRS1 and SHC1, as well as of the MAP kinases MAPK1/ERK2 and MAPK3/ERK1 (PubMed : 15226403, PubMed : 16878150). ALK activation may also be regulated by pleiotrophin (PTN) and midkine (MDK) (PubMed : 11278720, PubMed : 11809760, PubMed : 12107166, PubMed : 12122009). PTN-binding induces MAPK pathway activation, which is important for the anti-apoptotic signaling of PTN and regulation of cell proliferation (PubMed : 11278720, PubMed : 11809760, PubMed : 12107166). MDK-binding induces phosphorylation of the ALK target insulin receptor substrate (IRS1), activates mitogen-activated protein kinases (MAPKs) and PI3-kinase, resulting also in cell proliferation induction (PubMed : 12122009). Drives NF-kappa-B activation, probably through IRS1 and the activation of the AKT serine/threonine kinase (PubMed : 15226403, PubMed : 16878150). Recruitment of IRS1 to activated ALK and the activation of NF-kappa-B are essential for the autocrine growth and survival signaling of MDK (PubMed : 15226403, PubMed : 16878150). May function as regulator of gastric epithelial differentiation (By similarity).
See full target information ALK

Publications (25)

Recent publications for all applications. Explore the full list and refine your search

International journal of molecular sciences 23: PubMed36142468

2022

Comparison between Immunocytochemistry, FISH and NGS for and Rearrangement Detection in Cytological Samples.

Applications

Unspecified application

Species

Unspecified reactive species

Diane Frankel,Isabelle Nanni,L'Houcine Ouafik,Clara Camilla,Eric Pellegrino,Nathalie Beaufils,Laurent Greillier,Hervé Dutau,Philippe Astoul,Elise Kaspi,Patrice Roll

Applied immunohistochemistry & molecular morphology : AIMM 30:477-485 PubMed35876743

2022

Digital Image Analysis and Quantitative Bead Standards in Root Cause Analysis of Immunohistochemical Staining Variability: A Real-world Example.

Applications

Unspecified application

Species

Unspecified reactive species

Rebecca Rojansky,Seshi R Sompuram,Ellen Gomulia,Yasodha Natkunam,Megan L Troxell,Sebastian Fernandez-Pol

Methods in molecular biology (Clifton, N.J.) 2279:157-164 PubMed33683692

2021

Immunocytochemical Detection of ALK and ROS1 Rearrangements in Lung Cancer Cytological Samples.

Applications

Unspecified application

Species

Unspecified reactive species

Diane Frankel,Elise Kaspi,Patrice Roll

The American journal of surgical pathology 45:653-661 PubMed33399341

2021

Pediatric Mesothelioma With ALK Fusions: A Molecular and Pathologic Study of 5 Cases.

Applications

Unspecified application

Species

Unspecified reactive species

Pedram Argani,Derrick W Q Lian,Abbas Agaimy,Markus Metzler,Sara E Wobker,Andres Matoso,Jonathan I Epstein,Yun-Shao Sung,Lei Zhang,Cristina R Antonescu

Pathology oncology research : POR 26:2795-2800 PubMed31407221

2019

Clinicopathological and Molecular Study of Peritoneal Carcinomatosis Associated with Non-Small Cell Lung Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Hussein Nassereddine,Aurélie Sannier,Solenn Brosseau,Jean-Michel Rodier,Antoine Khalil,Simon Msika,Claire Danel,Anne Couvelard,Nathalie Théou-Anton,Aurélie Cazes

Case reports in oncological medicine 2019:5064852 PubMed31485361

2019

Annexin A2 Expression in Aerogenous Metastasis of Pulmonary Invasive Mucinous Adenocarcinoma: A Case Report including Immunohistochemical Analysis.

Applications

Unspecified application

Species

Unspecified reactive species

Kazumori Arai,Masahide Hirose

Translational oncology 12:784-787 PubMed30909092

2019

Isolated 5' Signals Are an Atypical Pattern To Be Considered as Positive for ALK Rearrangement: A Brief Report of Three Cases and Review of the Literature.

Applications

Unspecified application

Species

Unspecified reactive species

Alice Guyard,Cécile Charpy,Nathalie Théou-Anton,Anne Cremades,Frédéric Grassin,Anaïs Bourgogne,Karen Leroy,Anaïs Pujals,Christiane Copie-Bergman,Christos Chouaid,Audrey Mansuet-Lupo

Blood 131:1576-1586 PubMed29437595

2018

Integrated molecular profiling of juvenile myelomonocytic leukemia.

Applications

Unspecified application

Species

Unspecified reactive species

Norihiro Murakami,Yusuke Okuno,Kenichi Yoshida,Yuichi Shiraishi,Genta Nagae,Kyogo Suzuki,Atsushi Narita,Hirotoshi Sakaguchi,Nozomu Kawashima,Xinan Wang,Yinyan Xu,Kenichi Chiba,Hiroko Tanaka,Asahito Hama,Masashi Sanada,Masafumi Ito,Masashi Hirayama,Arata Watanabe,Toshihide Ueno,Seiji Kojima,Hiroyuki Aburatani,Hiroyuki Mano,Satoru Miyano,Seishi Ogawa,Yoshiyuki Takahashi,Hideki Muramatsu

Journal of thoracic disease 9:S1391-S1396 PubMed29184678

2017

Liquid biopsy for monitoring anaplastic lymphoma kinase inhibitors in non-small cell lung cancer: two cases compared.

Applications

Unspecified application

Species

Unspecified reactive species

Mariangela Manicone,Maria Chiara Scaini,Maria Grazia Rodriquenz,Antonella Facchinetti,Alfredo Tartarone,Michele Aieta,Rita Zamarchi,Elisabetta Rossi

Journal of thoracic disease 9:S1359-S1363 PubMed29184674

2017

Molecular characterization and prognostic significance of circulating tumor cells in patients with non-small cell lung cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Alfredo Tartarone,Rosa Lerose,Maria Grazia Rodriquenz,Giuseppina Mambella,Giuseppe Calderoni,Giovanni Bozza,Michele Aieta
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com